Finance

Lists
BIM:EPA
BioMerieux SA
81,20 €
+0,56%
(+0,45) 1D
8 қаз., 15:34:07 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for BIM...
Open
80,20 €
High
81,35 €
Low
79,55 €
Mkt. cap
9,37 млрд
Avg. vol.
166,95 м.
Volume
23,50 мың
P/E ratio
20,81
52-wk high
116,10 €
52-wk low
65,60 €
EPS
3,90 €
Shares outstanding
118,36 млн
No. of employees
15 мың
Open
80,20 €
High
81,35 €
Low
79,55 €
Mkt. cap
9,37 млрд
Avg. vol.
166,95 м.
Volume
23,50 мың
P/E ratio
20,81
52-wk high
116,10 €
52-wk low
65,60 €
EPS
3,90 €
Shares outstanding
118,36 млн
No. of employees
15 мың
News stories
From web sources and news partners
Yahoo Finance Singapore
Yahoo Finance Singapore
·
6 сағат бұрын
bioMérieux (ENXTPA:BIM) Launches SPINCHIP, Is The Stock Fully Priced?
Profile
bioMérieux SA is a French multinational biotechnology company founded and headquartered in Marcy-l'Étoile, France, close to Lyon. bioMérieux is present in 44 countries and serves more than 160 countries through a large network of distributors. bioMérieux provides diagnostic solutions which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases, cancer screening, and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the Euronext Paris stock exchange. Wikipedia
About BioMerieux SA
CEOPierre Boulud
Employees14,9 мың
Founded1963
HeadquartersMarcy-l'Étoile, Рона-Альпі, Франция
SectorMedical device
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
1,01 млрд
1,01 млрд
982,30 млн
982,30 млн
Cost of goods sold
442,05 млн
442,05 млн
433,20 млн
433,20 млн
Cost of revenue
442,05 млн
442,05 млн
433,20 млн
433,20 млн
Research and development expenses
129,00 млн
129,00 млн
128,70 млн
128,70 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
271,20 млн
271,20 млн
272,15 млн
272,15 млн
Operating expense
400,65 млн
400,65 млн
399,50 млн
399,50 млн
Total operating expenses
842,70 млн
842,70 млн
832,70 млн
832,70 млн
Operating income
170,30 млн
170,30 млн
149,60 млн
149,60 млн
Other non operating income
-
-
200,00 м.
200,00 м.
EBT including unusual items
156,25 млн
156,25 млн
147,30 млн
147,30 млн
EBT excluding unusual items
171,85 млн
171,85 млн
148,60 млн
148,60 млн
Income tax expense
38,10 млн
38,10 млн
34,40 млн
34,40 млн
Effective tax rate
24,38%
24,38%
23,35%
23,35%
Other operating expenses
-7,30 млн
-7,30 млн
-8,45 млн
-8,45 млн
Net income
118,25 млн
118,25 млн
113,05 млн
113,05 млн
Net profit margin
11,67%
11,67%
11,51%
11,51%
Earnings per share
-
-
-
-
Interest and investment income
3,30 млн
3,30 млн
3,95 млн
3,95 млн
Interest expense
-4,20 млн
-4,20 млн
-3,85 млн
-3,85 млн
Net interest expenses
-900,00 м.
-900,00 м.
100,00 м.
100,00 м.
Depreciation and amortization charges
7,75 млн
7,75 млн
-
-
EBITDA
327,00 млн
327,00 млн
207,75 млн
207,75 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары